Holen Sie sich die Stockscreener-App
1.51
1.34%
0.02
Handel nachbörslich:
1.47
-0.04
-2.65%
Schlusskurs vom Vortag:
$1.49
Offen:
$1.49
24-Stunden-Volumen:
401.58K
Relative Volume:
0.42
Marktkapitalisierung:
$10.57M
Einnahmen:
$5.75M
Nettoeinkommen (Verlust:
$-38.96M
KGV:
-0.1211
EPS:
-12.47
Netto-Cashflow:
$-32.63M
1W Leistung:
-7.93%
1M Leistung:
-91.89%
6M Leistung:
-56.73%
1J Leistung:
-70.79%
1-Tages-Spanne:
$1.40
$1.52
1-Wochen-Bereich:
$1.40
$1.70
52-Wochen-Spanne:
$1.10
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Firmenname
Kala Bio Inc
Sektor
Branche
Telefon
781-996-5252
Adresse
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Vergleichen Sie KALA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
1.505 | 10.46M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-09-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Eingeleitet | Mizuho | Outperform |
| 2025-07-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-07-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-05-27 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Kala Bio Inc Aktie (KALA) Neueste Nachrichten
What to expect from KALA BIO Inc. in the next 30 daysWeekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
How supply chain issues affect KALA BIO Inc. stockTrade Entry Report & Expert Approved Trade Ideas - newser.com
Using fundamentals and technicals on KALA BIO Inc.Treasury Yields & Safe Swing Trade Setup Alerts - newser.com
Intraday pattern recognizer results for KALA BIO Inc.CEO Change & AI Forecasted Entry/Exit Points - newser.com
Volume spikes in KALA BIO Inc. stock – what they meanJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Is KALA BIO Inc. stock a contrarian buyJuly 2025 Closing Moves & Short-Term Trading Alerts - newser.com
How sentiment analysis helps forecast KALA BIO Inc.Trend Reversal & Daily Momentum Trading Reports - newser.com
How hedge fund analytics apply to KALA BIO Inc. stockJuly 2025 Final Week & Capital Protection Trading Alerts - newser.com
KALA BIO Inc. stock prediction for this weekPortfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
Custom watchlist performance reports with KALA BIO Inc.CEO Change & Verified Short-Term Plans - newser.com
BAKER BROS. ADVISORS LP Increases Stake in Kala Bio Inc. - GuruFocus
KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure - The Globe and Mail
Is KALA BIO Inc a good long term investmentStock Rotation Strategies & Turn Market Volatility into Wealth - earlytimes.in
Is KALA BIO Inc. meeting your algorithmic filter criteria2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Quantitative breakdown of KALA BIO Inc. recent moveWeekly Investment Recap & Weekly Top Stock Performers List - newser.com
Forecasting KALA BIO Inc. price range with options dataJuly 2025 Retail & Technical Pattern Alert System - newser.com
Candlestick signals on KALA BIO Inc. stock todayWeekly Stock Recap & Real-Time Volume Analysis - newser.com
Mizuho Securities Downgrades KALA BIO(KALA.US) to Hold Rating, Cuts Target Price to $1.5 - 富途牛牛
Is KALA BIO Inc. stock supported by strong cash flowsJuly 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs - Eyes On Eyecare
Can KALA BIO Inc. stock surprise with earnings upsideNew Guidance & Safe Entry Momentum Tips - newser.com
Q3 Earnings Estimate for KALA BIO Issued By Lifesci Capital - Defense World
Published on: 2025-10-01 09:01:05 - newser.com
Kala Bio receives notice of event of default from Oxford Finance LLCSEC filing - MarketScreener
Kala Bio receives default notice, $29.1 million loan declared immediately due - Investing.com India
Kala Bio receives default notice, $29.1 million loan declared immediately due By Investing.com - Investing.com South Africa
KALA BIO, Inc. Receives Default Notice from Oxford Finance with Respect to Certain Loan and Security Agreement - MarketScreener
KALA BIO (NASDAQ:KALA) Rating Lowered to “Hold” at Lifesci Capital - Defense World
KALA BIO, Inc. Securities Lawsuit Investigation - Claim Depot
Kala Bio Shares Fall After Downgrade From Mizuho - MarketScreener
A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize
Kala Bio Faces Diminishing Options After Eye Drug Failure - insights.citeline.com
Mizuho Downgrades KALA BIO to Neutral From Outperform, Price Target is $1.50 - MarketScreener
Kala Bio tanks on Phase IIb KPI-012 miss - The Pharma Letter
KALA BIO (NASDAQ:KALA) Downgraded to Hold Rating by Lifesci Capital - MarketBeat
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure - Medical Dialogues
Electronic Arts, Kala Bio, Semtech - TradingView
KALA BIO (NASDAQ:KALA) Downgraded to “Neutral” Rating by LADENBURG THALM/SH SH - Defense World
KALA BIO (KALA) Price Target Increased by 23.00% to 31.36 - Nasdaq
Finanzdaten der Kala Bio Inc-Aktie (KALA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kala Bio Inc-Aktie (KALA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Former 10% owner |
Sep 30 '25 |
Sale |
1.60 |
216,801 |
345,993 |
97,120 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Jun 24 '25 |
Sale |
4.01 |
4,511 |
18,089 |
62,566 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Jun 24 '25 |
Sale |
4.01 |
3,631 |
14,560 |
62,100 |
| Bazemore Todd | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
4,058 |
16,273 |
83,699 |
| Brazzell Romulus K | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
5,251 |
21,057 |
82,698 |
| Iwicki Mark T | Director |
Jun 24 '25 |
Sale |
4.01 |
13,227 |
53,040 |
258,433 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):